GlassScriptPhysician profile
Timothy S Reid
NPI 1023160520
$70,860.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $15K · 2021: $156.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $47,946.26 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $20,318.52 | 2019-2022 | |
| Becton, Dickinson and Company | $1,125.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $740.23 | 2019-2020 | |
| Dexcom, INC. | $155.66 | 2019 | |
| Merck Sharp & Dohme LLC | $119.63 | 2019 | |
| Janssen Scientific Affairs, LLC | $88.10 | 2019 | |
| Genzyme Corporation | $70.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $69.13 | 2019 | |
| Amarin Pharma, INC. | $63.36 | 2019 | |
| Abbott Laboratories | $57.25 | 2019 | |
| Ascensia Diabetes Care US INC. | $39.30 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.85 | 2019 | |
| Medtronic Minimed, INC. | $14.51 | 2019 | |
| Lifescan, INC. | $13.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $10.00 | 2019 |
Research and ownership
$2,750.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.